Navigation Links
Saint-Gobain Adds High Purity Hose Option to Sani-Tech® Line
Date:1/23/2012

BRIDGEWATER, N.J., Jan. 23, 2012 /PRNewswire/ -- Saint-Gobain has expanded its Sani-Tech® line of fluid transfer products with the introduction of Sani-Tech® Ultra-HP high purity hose. Ultra-HP combines a tough outer jacket and hose comprising multiple layers of Sani-Tech® Ultra platinum-cured silicone and 316L stainless steel helical wire reinforcement with a PharmaFluor® FEP liner. The liner's smooth inner bore surface provides both optimal flow and ease of cleaning and sanitization.

The PharmaFluor® FEP liner minimizes bonding of biological materials and maintains fluid purity due to low TOCs, extractables and leachables. The liner is fully bonded to the silicone hose utilizing patented bonding technology, which helps ensure a high purity fluid path.

Sani-Tech® Ultra-HP hose is manufactured to tight dimensional tolerances, which simplifies the assembly procedure. The hose's overall light weight, low force to bend and exceptional flexibility make it very user-friendly. It is suitable for a variety of applications, including bioprocessing, load cells, product transfer and steam-in-place/clean-in-place (SIP/CIP).

Sani-Tech® Ultra-HP hose is constructed from USP Class VI compliant materials and certified to meet USP <88>, USP <87>, EP 3.1.9, ISO 10993, FDA 21 CFR 177.2600 and FDA 21 CFR 177.1550 requirements.

For more information on Sani-Tech® Ultra-HP high purity hose and the many other products offered by Saint-Gobain, visit http://www.biopharm.saint-gobain.com.

About Saint-Gobain Performance Plastics

Saint-Gobain Performance Plastics, part of the Innovative Materials Sector of Saint-Gobain, is headquartered in Aurora, Ohio, and employs 4,000 people in 16 countries. It is a world leader in high-performance plastics, including flexible tubing applications, seals, coated fabrics, foams, polymer products and bearings.

About Saint-Gobain

Based in Paris, Saint-Gobain has operations in 64 countries and employs nearly 190,000 people. Founded in 1665 to manufacture glass for the Hall of Mirrors at the Palace of Versailles in Paris, Saint-Gobain remains headquartered in France and had worldwide sales of $53.2 billion in 2010. The company has 19,000 employees in more than 350 locations across the United States and Canada. For more information, visit www.saint-gobain.com and www.saint-gobain-northamerica.com.

Contact: Carla Conant
Saint-Gobain Performance Plastics
2664 Gilchrist Road. Akron, OH 44305
Ph: 330-798-6931 / 800-798-1554
Email: Carla.S.Conant@Saint-Gobain.com

To download a photograph:
http://enewsletters.sgcreativeservices.net/Saint-Gobain/ppl/biopharm/RandomNewsletterImages/Sani-Tech-Ultra-HP.jpg


'/>"/>
SOURCE Saint-Gobain
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint-Gobains New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition
2. Saint-Gobain Introduces Laser Engraving for Hose Assemblies
3. Quercegen Pharmaceuticals LLC Obtains FDA GRAS Notified Status for its QU995™ Quercetin with Purity Greater than 99.5%
4. GSK Does Not Option XL784 for Further Development
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
8. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
9. ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer
10. New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
11. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/15/2017)... May 15, 2017  Amy Baxter MD, chief executive ... in noninvasive pain relief, was awarded a 2017 Top ... Baxter was recognized at the MM&M Top 40 Healthcare ... City on May 10, 2017. The dinner ... industry go "beyond the pill."  "Innovation goes ...
(Date:5/11/2017)... , May 11, 2017  Thornhill Research Inc. ... been awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery ... the Canadian Commercial Corporation (CCC) ( Ottawa, ... Systems to administer general anesthesia to patients requiring ... "The US Marine Corps have been a ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... female reproductive tract in which the endometrial lining of the uterus spreads ... and pain. Patients experiencing painful intercourse, painful periods, pelvic pain, or irregular ...
(Date:5/24/2017)... , ... May 24, 2017 , ... Rob Lowe is ... “Informed,” developed for Public Television. “Informed” brings the public important topics from all aspects ... treatment of the feet and issues surrounding feet and ankles. , Podiatry is essential ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a leading ... that its iClinic V12.2 solution has achieved approval from National Center for Quality ... 2017 standards which emphasize team-based care with a significant focus on the care ...
(Date:5/23/2017)... ... , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations and ... Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s Regulations ... today reported on a new study released on May 21, 2017 in the New ...
Breaking Medicine News(10 mins):